The efficacy of Origanum majorana nanocubosomal systems in ameliorating submandibular salivary gland alterations in streptozotocin-induced diabetic rats.
Dina B E FaragCarol YousryAbdulaziz Mohsen Al-MahallawiHesham I El-AskaryMeselhy Ragab MeselhyNermeen AbuBakrPublished in: Drug delivery (2022)
Diabetes mellitus is a challenging health problem. Salivary gland dysfunction is one of its complications. Current treatments possess numerous adverse effects. Therefore, herbal extracts have emerged as a promising approach for safe and effective treatment. However, they are required in large doses to achieve the desired effect. Accordingly, Origanum majorana extract (OE) was incorporated into nano-sized systems to enhance its biological effects at lower dosages. OE was standardized against rosmarinic acid (RA) and then loaded into nano-cubosomal (NC) systems via a 2 3 full-factorial design. Two optimum nano-systems at different drug loads (2.08 or 1.04 mg-RA/mL) were selected and assessed in vivo to compare their effects in streptozotocin-induced diabetic rats against conventional OE (2.08 mg-RA/mL). Blood glucose was evaluated weekly. Submandibular salivary glands were processed for histopathological examination and nuclear factor-erythroid 2-related factor 2 ( Nrf2 ), Kelch-like ECH-associated protein 1 ( Keap1 ), and p38-MAPK gene expression analysis. NC systems were successfully prepared and optimized where the optimum systems showed nano-sized vesicles (210.4-368.3 nm) and high zeta potential values. In vivo results showed a significant lower blood glucose in all treated groups, with an exceptional reduction with NC formulations. Marked histopathological improvement was observed in all OE - treated groups, with OE-NC4 (2.08 mg-RA/mL) demonstrating the best features. This was supported by RT-PCR; where the OE-NC4 group recorded the highest mean value of Nrf2 and the least mean values of Keap1 and p38-MAPK , followed by OE-NC3 and OE groups. In conclusion, OE-loaded NC enhanced the anti-hyperglycemic effect of OE and ameliorated diabetic gland alterations compared to conventional OE. Thus, cubosomal nano-systems could be anticipated as potential carriers for the best outcome with OE.
Keyphrases
- diabetic rats
- oxidative stress
- blood glucose
- rheumatoid arthritis
- nuclear factor
- type diabetes
- drug delivery
- healthcare
- public health
- disease activity
- mental health
- glycemic control
- high fat diet
- emergency department
- risk assessment
- wound healing
- systemic lupus erythematosus
- cancer therapy
- genome wide
- photodynamic therapy
- endothelial cells
- dna methylation
- toll like receptor
- protein protein
- newly diagnosed
- small molecule
- idiopathic pulmonary fibrosis
- climate change
- risk factors
- diabetic nephropathy